Menu

An expert resource for medical professionals
Provided FREE as a service to women’s health

The Alliance for
Global Women’s Medicine
A worldwide fellowship of health professionals working together to
promote, advocate for and enhance the Welfare of Women everywhere

An Educational Platform for FIGO

The Global Library of Women’s Medicine
Clinical guidance and resourses

A vast range of expert online resources. A FREE and entirely CHARITABLE site to support women’s healthcare professionals

The Global Academy of Women’s Medicine
Teaching, research and Diplomates Association

Contraception, 2018 - http://www.safeabortionwomensright.org/medical-abortion-a-special-edition-of-contraception/

Efficacy of medical abortion prior to 6 gestational weeks: a systematic review

Kapp N, Baldwin MK and Rodriguez MI

Abstract

Objective: The objective was to describe the efficacy of medical abortion using mifepristone and misoprostol for gestations less than 6 weeks.

Study design: We searched PubMed and Cochrane databases for articles in any language that examined the success of mifepristone and misoprostol abortion at gestational ages up to 42 days. Data were independently abstracted by two authors and graded for evidence quality. A pooled analysis of efficacy and a summary odds ratio of abortion failure of before 42 days' gestation compared with gestational weeks of more than 6-7 were performed for randomized trials as well as for prospective studies.

Results: Six randomized controlled trials and nine prospective observational studies met inclusion criteria. Included studies varied greatly in regimens of mifepristone and misoprostol used, and assessment of and timing of outcome of abortion. A pooled proportion of the randomized trials estimated a proportion of unsuccessful abortion of 0.02 (95% confidence interval 0.01–0.03). In the prospective studies, the proportions ranged between 0.02 and 0.17, with considerable heterogeneity in the pooled estimate. However, the two largest observational studies reflected the estimates of the randomized trials (range 0.02–0.03). The summary odds ratios indicated that the odds of unsuccessful abortion were not significantly different between gestational age groups (before 42 days versus after 42–49 days).

Discussion: These analyses support the use of medical abortion at gestational ages before 42 days. Efficacy rates are high overall and appear to reflect those observed during the seventh week of pregnancy. Women who prefer to initiate treatment as soon as early pregnancy is diagnosed may do so without delay.

Implications: Women can expect success using medical abortion regimens as soon as pregnancy is diagnosed.

Comment: It is important for women to know that medication for safe medical abortion can be taken as soon as she knows that she is pregnant. (HMV)